22 gennaio 2025|
AI
|11 months agoSwissmedic Clashes with Media Over Weight-Loss Drug Coverage
Swiss medicines regulator takes legal action against media houses over alleged unauthorized advertising of weight-loss drugs Ozempic and Wegovy.
AI
Generated IllustrationKey Takeaways
AI
- Swissmedic has ordered three major Swiss media groups to delete online articles about weight-loss drugs under threat of punishment.
- The media groups targeted include Neue ZĂźrcher Zeitung (NZZ), Ringier, and 20 Minuten.
- Swissmedic bases its legal action on the Therapeutic Products Law, which bans public advertising for prescription drugs.
- Ozempic is authorized in Switzerland for Type 2 diabetes, not weight loss, though it is prescribed off-label.
By The Numbers
Over 840
media reports
12%
of the population
$100 billion
market value
1 billion
people
They Said
"The interpretation of the law by Swissmedic goes too far so that almost all editorial content could suddenly be considered an advertisement."
"How to lose weight is part and should remain part of the public discussion."
1
Regulator Launches Legal Offensive
2
Media Hype Meets Regulatory Iron Fist
3
The Billion-Dollar Obesity Crisis
4